These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25153355)

  • 1. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.
    Klauzinska M; Castro NP; Rangel MC; Spike BT; Gray PC; Bertolette D; Cuttitta F; Salomon D
    Semin Cancer Biol; 2014 Dec; 29():51-8. PubMed ID: 25153355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
    Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
    Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells.
    Wu D; Shi Z; Xu H; Chen R; Xue S; Sun X
    J Biosci; 2017 Sep; 42(3):405-416. PubMed ID: 29358554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
    Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
    Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
    Liu Y; Qin Z; Yang K; Liu R; Xu Y
    Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.
    Gray PC; Vale W
    FEBS Lett; 2012 Jul; 586(14):1836-45. PubMed ID: 22306319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.
    Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C
    Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.
    Saloman DS; Bianco C; Ebert AD; Khan NI; De Santis M; Normanno N; Wechselberger C; Seno M; Williams K; Sanicola M; Foley S; Gullick WJ; Persico G
    Endocr Relat Cancer; 2000 Dec; 7(4):199-226. PubMed ID: 11174844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Cripto-1 in stem cell maintenance and malignant progression.
    Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
    Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
    Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
    Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
    Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.
    Aykul S; Parenti A; Chu KY; Reske J; Floer M; Ralston A; Martinez-Hackert E
    J Biol Chem; 2017 Mar; 292(10):4138-4151. PubMed ID: 28126904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.
    Ruggiero D; Nappo S; Nutile T; Sorice R; Talotta F; Giorgio E; Bellenguez C; Leutenegger AL; Liguori GL; Ciullo M
    PLoS Genet; 2015 Jan; 11(1):e1004976. PubMed ID: 25629528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
    Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
    Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor.
    Watanabe K; Hamada S; Bianco C; Mancino M; Nagaoka T; Gonzales M; Bailly V; Strizzi L; Salomon DS
    J Biol Chem; 2007 Dec; 282(49):35772-86. PubMed ID: 17925387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
    Yuki R
    Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evolving web of signaling networks regulated by Cripto-1.
    Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
    Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
    Terry S; El-Sayed IY; Destouches D; Maillé P; Nicolaiew N; Ploussard G; Semprez F; Pimpie C; Beltran H; Londono-Vallejo A; Allory Y; de la Taille A; Salomon DS; Vacherot F
    Oncotarget; 2015 May; 6(14):11994-2008. PubMed ID: 25596738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.